Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans” ; volume:17 ; number:1 ; day:8 ; month:11 ; year:2017 ; pages:1 ; date:12.2017
BMC gastroenterology ; 17, Heft 1 (8.11.2017), 1, 12.2017
- Classification
-
Physik
- Creator
-
Persico, Marcello
- Contributor
-
Masarone, Mario
Damato, Antonio
Ambrosio, Mariateresa
Federico, Alessandro
Rosato, Valerio
Bucci, Tommaso
Carrizzo, Albino
Vecchione, Carmine
SpringerLink (Online service)
- DOI
-
10.1186/s12876-017-0671-0
- URN
-
urn:nbn:de:1111-2018010610709
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Persico, Marcello
- Masarone, Mario
- Damato, Antonio
- Ambrosio, Mariateresa
- Federico, Alessandro
- Rosato, Valerio
- Bucci, Tommaso
- Carrizzo, Albino
- Vecchione, Carmine
- SpringerLink (Online service)
Other Objects (12)
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
Endothelial eNOS and red blood cell eNOS independently regulate blood pressure and nitric oxide metabolites
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
Erythrozytäre eNOS : NO-Synthese und Aktivität
Non-alcoholic fatty liver disease
P2.33 Adiponectin Hormone, Hypertension and Endothelial Dysfunction in Non-Alcoholic Fatty Liver Disease Patients
Enos
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Auswirkungen akuter körperlicher Belastung auf die erythrozytäre eNOS
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
Endothelial eNOS and red blood cell eNOS independently regulate blood pressure and nitric oxide metabolites
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
Erythrozytäre eNOS : NO-Synthese und Aktivität
Non-alcoholic fatty liver disease
P2.33 Adiponectin Hormone, Hypertension and Endothelial Dysfunction in Non-Alcoholic Fatty Liver Disease Patients
Enos
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Auswirkungen akuter körperlicher Belastung auf die erythrozytäre eNOS
“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
Endothelial eNOS and red blood cell eNOS independently regulate blood pressure and nitric oxide metabolites
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
Erythrozytäre eNOS : NO-Synthese und Aktivität
Non-alcoholic fatty liver disease
P2.33 Adiponectin Hormone, Hypertension and Endothelial Dysfunction in Non-Alcoholic Fatty Liver Disease Patients
Enos
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease